The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy-Reference-Cited by-同舟云学术

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy

Published:2018-10-17 Issue:1 Volume:125 Page:127-134
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bilen Mehmet A.¹²^ORCID,Martini Dylan J.¹²,Liu Yuan³,Lewis Colleen²,Collins Hannah H.²,Shabto Julie M.¹²,Akce Mehmet¹²^ORCID,Kissick Haydn T.²⁴,Carthon Bradley C.¹²,Shaib Walid L.¹²,Alese Olatunji B.¹²,Pillai Rathi N.¹²,Steuer Conor E.¹²,Wu Christina S.¹²,Lawson David H.¹²,Kudchadkar Ragini R.¹²,El-Rayes Bassel F.¹²^ORCID,Master Viraj A.⁴,Ramalingam Suresh S.¹²^ORCID,Owonikoko Taofeek K.¹²,Harvey R. Donald¹²⁵

Affiliation:

1. Department of Hematology and Medical Oncology; Emory University School of Medicine; Atlanta Georgia

2. Winship Cancer Institute of Emory University; Atlanta Georgia

3. Departments of Biostatistics and Bioinformatics; Emory University; Atlanta Georgia

4. Department of Urology; Emory University School of Medicine; Atlanta Georgia

5. Department of Pharmacology; Emory University School of Medicine; Atlanta Georgia

Funder

Emory University

National Institutes of Health

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31778/fullpdf

Reference29 articles.

1. Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: a systematic analysis of the literature;Pillai;Cancer,2018

2. Durable clinical benefit in metastatic renal cell carcinoma patients who discontinue PD-1/PD-L1 therapy for immune-related adverse events;Martini;Cancer Immunol Res,2018

3. Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience;Arkenau;Br J Cancer,2008

4. US National Library of Medicine National Institutes of Health ClinicalTrials.gov [database] Bethesda, MD US National Library of Medicine, National Institutes of Health 2018 https://clinicaltrials.gov/

5. Angiopoietin-2 as a biomarker and target for immune checkpoint therapy;Wu;Cancer Immunol Res,2017

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-12

2. GLUT5-overexpression-related tumorigenic implications;Molecular Medicine;2024-08-06

3. Cytometry investigation of myo-inositol-induced growth inhibition, apoptosis induction and cell cycle arrest in the human prostate cancer cell line (DU-145).;Bangladesh Journal of Medical Science;2024-07-29

4. Revealing the effect of X-ray or proton brain irradiation on systemic inflammation and leukocyte subpopulation interplay in rodents;Journal of Leukocyte Biology;2024-07-02

5. Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?;Journal of Cancer Research and Clinical Oncology;2024-06-26